Home Cart 0 Sign in  

[ CAS No. 18807-71-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 18807-71-1
Chemical Structure| 18807-71-1
Structure of 18807-71-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 18807-71-1 ]

Related Doc. of [ 18807-71-1 ]

Alternatived Products of [ 18807-71-1 ]

Product Details of [ 18807-71-1 ]

CAS No. :18807-71-1 MDL No. :MFCD00270150
Formula : C10H15ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :QMLKQXIAPAAIEJ-UHFFFAOYSA-N
M.W : 230.69 Pubchem ID :12715871
Synonyms :

Calculated chemistry of [ 18807-71-1 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 6
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 59.98
TPSA : 64.35 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.54
Log Po/w (WLOGP) : 1.52
Log Po/w (MLOGP) : 1.25
Log Po/w (SILICOS-IT) : 0.77
Consensus Log Po/w : 1.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 1.67 mg/ml ; 0.00724 mol/l
Class : Soluble
Log S (Ali) : -2.5
Solubility : 0.728 mg/ml ; 0.00316 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.0
Solubility : 0.232 mg/ml ; 0.00101 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.07

Safety of [ 18807-71-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 18807-71-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 18807-71-1 ]
  • Downstream synthetic route of [ 18807-71-1 ]

[ 18807-71-1 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 18807-71-1 ]
  • [ 72080-83-2 ]
YieldReaction ConditionsOperation in experiment
99% With sodium hydrogencarbonate In water Preparation of benzyl (2-aminoethyl)carbamate To a solution of 2-(((benzyloxy)carbonyl)amino)ethanaminium chloride (1.0 g, 4.3 mmol) in water (5 mL) was added anhydrous Na2CO3 until litmus testing indicated pH 9. Solvent removal afforded a residue that was triturated with CH2Cl2 and filtered. The filtrate was concentrated to afford the desired free amine (0.93 g, 99percent yield).
Reference: [1] Patent: WO2015/81282, 2015, A1, . Location in patent: Paragraph 00714; 00715
  • 2
  • [ 77153-05-0 ]
  • [ 18807-71-1 ]
YieldReaction ConditionsOperation in experiment
85% With hydrogenchloride In methanol; ethyl acetate at 20℃; for 10 h; Preparation of 2-(((benzyloxy)carbonyl)amino)ethanaminium chloride Benzyl tert-butyl ethane-1,2-diyldicarbamate (1.5 g, 6.3 mmol) in MeOH (10 mL) was treated with HCl/EtOAc (2 mL). The reaction was stirred at room temperature for 10 h and concentrated to give the title compound (1.0 g, 85percent yield).
Reference: [1] Bulletin of the Chemical Society of Japan, 1998, vol. 71, # 3, p. 699 - 709
[2] Journal of Peptide Science, 2013, vol. 19, # 1, p. 9 - 15
[3] Patent: WO2015/81282, 2015, A1, . Location in patent: Paragraph 00712; 00713
  • 3
  • [ 13139-17-8 ]
  • [ 18807-71-1 ]
YieldReaction ConditionsOperation in experiment
68%
Stage #1: With ethylenediamine In dichloromethane for 2.5 h;
Stage #2: With hydrogenchloride In diethyl ether; hexane
Solid Phase Synthetic protocol: A solution of N-(benzyloxycarbonyloxy)succinimide (ZOSu, 100 g, 401 mmol) in dichloromethane (500 ml) was added dropwise over 2 hours to a solution of 5 ethylenediamine (1, 189 ml, 2.81 mol) in dichloromethane (750 ml). After 30 minutes the suspension was filtered and solids washed with dichloromethane. The filtrate was evaporated to dryness and the residue diluted with toluene (1.00 L) and water (0.50 L). The resulting mixture was filtered and the filtrate was separated to afford two phases. The aqueous phase contained the product; therefore it was extracted with 10 dichloromethane (2 x 250 ml). All organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was diluted with toluene (750 ml) and extracted with 2 M aqueous hydrochloric acid (500 ml) and 1 M aqueous hydrochloric acid (100 ml). Acidic aqueous phases were combined and basified with a solution of sodium hydroxide (60.0 g, 1.50 mol) in water (90 ml). The resulting mixture 15 was extracted with dichloromethane (4 x 200 ml), dried over anhydrous sodium sulfate, filtered, concentrated in vacuo and diluted with hexanes (200 ml). 4 M Solution of hydrogen chloride in ether (100 ml, 400 mmol) was added to the solution, the resulting suspension was concentrated in vacuo and diluted with hexanes (1.00 L). The precipitated solid was filtered, washed with hexanes and dried in vacuo to give (2-amino20 ethyl)-carbamic acid benzyl ester hydrochloride as white powder. 25 Yield: 62.62 g (68percent). RF (Si02, dichloromethane/methanol 4: 1): 0.25 (free base). 1H NMR spectrum (300 MHz, Ac0D-d4, 80 °C, dH): 7.42-7.26 (m, 5 H); 5.16 (s, 2 H); 3.60 (t, J=5.7 Hz, 2 H); 3.32 (t, J=5.7 Hz, 2 H).
Reference: [1] Patent: WO2017/220706, 2017, A1, . Location in patent: Page/Page column 52; 53
  • 4
  • [ 61495-86-1 ]
  • [ 18807-71-1 ]
Reference: [1] Patent: US6759509, 2004, B1,
  • 5
  • [ 72080-83-2 ]
  • [ 18807-71-1 ]
YieldReaction ConditionsOperation in experiment
62.62 g With hydrogenchloride In diethyl ether A solution of N-(benzyloxycarbonyloxy)succinimide (ZOSu, 100 g, 401 mmol) in dichloromethane (500 mL) was added dropwise over 2 hours to a solution ofethylenediamine (1, 189 mL, 2.81 mol) in dichloromethane (750 mL). After 30 minutes the suspension was filtered and solids washed with dichloromethane. The filtrate was evaporated to dryness and the residue diluted with toluene (1.00 L) and water (0.50 L). The resulting mixture was filtered and the filtrate was separated to afford two phases. The aqueous phase contained the product; therefore it was extracted withdichloromethane (2 x 250 mL). All organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was diluted with toluene (750 mL) and extracted with 2 M aqueous hydrochloric acid (500 mL) and 1 M aqueous hydrochloric acid (100 mL). Acidic aqueous phases were combined and basified with a solution of sodium hydroxide (60.0 g, 1.50 mol) in water (90 mL). The resulting mixture was extracted with dichloromethane (4 x 200 mL), dried over anhydrous sodium sulfate, filtered, concentrated in vacuo and diluted with hexanes (200 mL). 4 M Solution of hydrogen chloride in ether (100 mL, 400 mmol) was added to the solution, the resulting suspension was concentrated in vacuo and diluted with hexanes (1.00 L). Theprecipitated solid was filtered, washed with hexanes and dried in vacuo to give (2-amino- ethyl)-carbamic acid benzyl ester hydrochloride as white powder.Yield : 62.62 g (68percent).RF (Si02, dichloromethane/methanol 4: 1) : 0.25 (free base).1H NMR spectrum (300 MHz, AcOD-d4, 80 °C, dH) : 7.42-7.26 (m, 5 H); 5.16 (s, 2 H); 3.60 (t, J = 5.7 Hz, 2 H); 3.32 (t, J = 5.7 Hz, 2 H).
Reference: [1] Patent: WO2016/102562, 2016, A1, . Location in patent: Page/Page column 52
  • 6
  • [ 886-64-6 ]
  • [ 18807-71-1 ]
Reference: [1] Synthesis, 1996, # 10, p. 1246 - 1258
  • 7
  • [ 18807-67-5 ]
  • [ 18807-71-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 11, p. 1529 - 1532
  • 8
  • [ 501-53-1 ]
  • [ 107-15-3 ]
  • [ 18807-71-1 ]
Reference: [1] Agricultural and Biological Chemistry, 1989, vol. 53, # 11, p. 3111 - 3112
  • 9
  • [ 501-53-1 ]
  • [ 18807-71-1 ]
Reference: [1] Journal of Peptide Science, 2013, vol. 19, # 1, p. 9 - 15
[2] Patent: WO2015/81282, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 18807-71-1 ]

Aryls

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.98

Chemical Structure| 850033-71-5

[ 850033-71-5 ]

(S)-Benzyl (1-aminopropan-2-yl)carbamate hydrochloride

Similarity: 0.94

Chemical Structure| 1203099-07-3

[ 1203099-07-3 ]

Benzyl azetidin-3-ylcarbamate hydrochloride

Similarity: 0.92

Chemical Structure| 162576-01-4

[ 162576-01-4 ]

Benzyl (2-aminoethyl)(methyl)carbamate hydrochloride

Similarity: 0.92

Chemical Structure| 850033-67-9

[ 850033-67-9 ]

2-N-Cbz-2-Methylpropane-1,2-diamine hydrochloride

Similarity: 0.91

Amides

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.98

Chemical Structure| 850033-71-5

[ 850033-71-5 ]

(S)-Benzyl (1-aminopropan-2-yl)carbamate hydrochloride

Similarity: 0.94

Chemical Structure| 1203099-07-3

[ 1203099-07-3 ]

Benzyl azetidin-3-ylcarbamate hydrochloride

Similarity: 0.92

Chemical Structure| 162576-01-4

[ 162576-01-4 ]

Benzyl (2-aminoethyl)(methyl)carbamate hydrochloride

Similarity: 0.92

Chemical Structure| 850033-67-9

[ 850033-67-9 ]

2-N-Cbz-2-Methylpropane-1,2-diamine hydrochloride

Similarity: 0.91

Amines

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.98

Chemical Structure| 850033-71-5

[ 850033-71-5 ]

(S)-Benzyl (1-aminopropan-2-yl)carbamate hydrochloride

Similarity: 0.94

Chemical Structure| 1203099-07-3

[ 1203099-07-3 ]

Benzyl azetidin-3-ylcarbamate hydrochloride

Similarity: 0.92

Chemical Structure| 162576-01-4

[ 162576-01-4 ]

Benzyl (2-aminoethyl)(methyl)carbamate hydrochloride

Similarity: 0.92

Chemical Structure| 850033-67-9

[ 850033-67-9 ]

2-N-Cbz-2-Methylpropane-1,2-diamine hydrochloride

Similarity: 0.91